Acute Heart Failure Market

1. Acute Heart Failure Market to Grow Positively at a Paltry CAGR During the Study Period (2019–2032), Assesses DelveInsight New York, Nevada, Las Vegas, DelveInsight’s “Acute Heart Failure - Market Insight, Epidemiology and Market Forecast – 2032” report provides current treatment practices, emerging drugs, Acute Heart Failure market share of the individual therapies, current and forecasted Acute Heart Failure market size from 2019 to 2032 segmented by seven major markets. The report also offers current Acute Heart Failure therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute Heart Failure market. Acute Heart Failure Overview Heart Failure (HF) is also known as congestive heart failure. It is also bifurcated as left-side HF (when the heart is unable to pump enough oxygen in the blood to the body) and right-side HF (when the heart is unable to fill itself with enough blood). Another term for HF is corpulmonale which means that right-side HF is caused by high blood pressure in the pulmonary arteries and right ventricle. There are two types of heart failure: acute and chronic. Acute heart failure has a sudden onset and symptoms can appear without warning. However, in chronic heart failure, that difficulty is ongoing and long-term. It was observed that majority of patients are affected with Chronic heart failure. Acute heart failure (AHF) is a kind of syndrome that is defined as the new onset (de novo heart failure (HF)) or worsening (acutely decompensated heart failure (ADHF)) of symptoms and signs of HF, mostly related to systemic congestion. The clinical presentation of AHF is characterized mostly by symptoms and signs related to systemic congestion (that is, extracellular fluid accumulation, initiated by increased biventricular cardiac filling pressures). Symptoms of acute heart failure include: Shortness of breath while moving or lying flat, also known as dyspnea, Feeling tired, Swelling of feet, ankles, legs, abdomen or veins in the neck, among others. Acute Heart Failure Epidemiological Insights According to the study conducted by Mozaffarian et al. (2015), acute heart failure constitutes the first reason for hospital admission in the elderly, with a total of approximately 1 million admissions per year in the US and a similar number in Europe. Acute Heart Failure Treatment Market Congestive HF is a morbidity that is increasing worldwide due to the aging population and improvement in (acute) care for patients with cardiovascular diseases. The prognosis for patients with HF is very poor without treatment. Furthermore, hospitalizations for cardiac decompensation cause an increasing economic burden. It is a chronic long-term condition that gets worse with time. There are four stages of heart failure (Stage A, B, C and D). The stages range from "high risk of developing heart

2. failure" to "advanced heart failure," and provide treatment plans. These stages are different from the New York Heart Association (NYHA) clinical classifications of heart failure (Class I-II-III-IV) that reflect the severity of symptoms or functional limits due to heart failure (Cowie, 2017)(Tanaka, Sawano, Ramani, Friedman, & Kohsaka, 2018). Globally, acute heart failure (AHF) remains an ongoing public health issue with its prevalence and mortality increasing in the east and the west. Almost 6 million Americans have heart failure, and there are an additional 500,000 new cases diagnosed each year. According to the Centers for Disease Control and Prevention (CDC), about 5.7 million adults in the United States have heart failure. Heart failure happens when the heart cannot pump enough blood and oxygen to support other organs in the body. Heart failure is a serious condition, but it does not mean that the heart has stopped beating. About half of people who develop heart failure die within 5 years of diagnosis. Acute heart failure can be severe and anyone with symptoms should see a clinician as soon as possible. Treatment is initially focused on alleviating life-threatening symptoms, then on the examination of underlying causes and treatment of residual symptoms. Hospitalization is generally required while cardiac performance improves. There are a range of potential treatments for acute heart failure. The treatment that is applied will depend on the person’s symptoms and the underlying issue causing them. For an instance Shortness of breath (dyspnea): This symptom is treated with supplemental oxygen. The severity of dyspnea will dictate whether oxygen is supplied through a tube in the nose or a face mask. Sitting upright can help with breathing. Buildup of fluid: Intravenous diuretics are used to treat buildup of fluid within the body. A pulmonary edema will also be treated with diuretics, as well as oxygen and heart failure medication. Promising Therapies in the Acute Heart Failure Pipeline ● Empagliflozin ● Forxiga ● APD418 ● And others Discover more about Acute Heart Failure therapies in the pipeline @ Acute Heart Failure Drugs Leading Companies Working in the Acute Heart Failure Market ● Boehringer Ingelheim ● Eli Lilly and Company ● AstraZeneca ● And others To understand key companies related to the snapshot of the Acute Heart Failure Regulatory and Patent Analysis. Acute Heart Failure Market, get a

3. Scope of the Acute Heart Failure Market Report Study Period: 2019–2032 Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), Japan] Key Acute Heart Failure Companies: Boehringer Ingelheim, Eli Lilly and Company, AstraZeneca, and others Key Acute Heart Failure Pipeline Therapies: Empagliflozin, Forxiga, APD418, and others Therapeutic Assessment: Acute Heart Failure current marketed and emerging therapies Acute Heart Failure Market Dynamics: Acute Heart Failure market drivers and barriers Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies Unmet Needs, KOL’s views, Analyst’s views, Acute Heart Failure Market Access and Reimbursement Table of Contents 1. Acute Heart Failure Market Key Insights 2. Acute Heart Failure Market Report Introduction 3. Acute Heart Failure Market Overview at a Glance 4. Acute Heart Failure Market Executive Summary 5. Disease Background and Overview 6. Acute Heart Failure Treatment and Management 7. Acute Heart Failure Epidemiology and Patient Population 8. Patient Journey 9. Acute Heart Failure Emerging Drugs 10. 7MM Acute Heart Failure Market Analysis 11. Acute Heart Failure Market Outlook 12. Potential of Current and Emerging Therapies 13. KOL Views

4. 14. Acute Heart Failure Market Drivers 15. Acute Heart Failure Market Barriers 16. Unmet Needs 17. SWOT Analysis 18. Appendix 19. DelveInsight Capabilities 20. Disclaimer 21. About DelveInsight Trending Reports by DelveInsight: Adalimumab Biosimilar Market | Arbovirus Infection Market | Artificial Pancreas Device System Market | Dental Equipment Market | Gluten Sensitivity Market | Hypothyroidism Market | Inflammatory Bowel Disease Market | Mayus Kinase Jak Inhibitors Market | Mild Dry Eye Market | Mucopolysaccharidosis Market | Oncolytic Virus Cancer Therapy Market | Pyoderma Gangrenosum Market | Transdermal Drug Delivery Devices Market | Intrathecal Pumps Market | Hedgehog Pathway Inhibitors Market | Yellow Fever Market | Laryngeal Cancer Market | Female Infertility Market | Gender Dysphoria Market | Chronic Brain Damage Market | Spain Healthcare Outlook Market | Malignant Fibrous Histiocytoma Market | Asthma Diagnostic Devices Market | Chronic Obstructive Pulmonary Disease Treatment Devices Market | Airway Management Devices Market | Cough Assist Devices Market | Pulse Oximeters Market | Hemodialysis Catheter Devices Market | Chronic Spontaneous Urticaria Market | Gender Dysphoria Market | Germany Healthcare Outlook | Biopsy Devices Pipeline Insight | Bacterial Conjunctivitis Market | Infliximab Biosimilar Insight | Eosinophilic Asthma Market | Cushing Syndrome Market | Functional Dyspepsia Market | Peripherally Inserted Central Catheters (PICC) Devices Market About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve. Contact Us Kritika Rehani

5. info@delveinsight.com +91-9650213330